Interferon alpha-2A treatment for serpiginous choroiditis

Ocular Immunology and Inflammation

Volumn 13, Issue 1, 2005, Pages 59-66

  Sobaci, Güngör ^a,b   Bayraktar, Zeki ^a   Bayer, Atilla ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b GATF Gö üs Hastaliklari Anabilim Dali   (Turkey)

Author keywords

Chlorambucil; Cyclosporine A; Interferon alpha; Serpiginous choroiditis

Indexed keywords

ALPHA2A INTERFERON; CHLORAMBUCIL; CYCLOSPORIN A; PREDNISONE; STEROID; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARGON LASER; ARTICLE; CHOROIDITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; HUMAN; LASER COAGULATION; MALE; RECURRENT DISEASE; TREATMENT OUTCOME; VISUAL IMPAIRMENT; CASE REPORT; FLUORESCENCE ANGIOGRAPHY; MIDDLE AGED; PROSPECTIVE STUDY; VISUAL ACUITY;

ADULT; AGED; CHOROIDITIS; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON ALFA-2A; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VISUAL ACUITY;

EID: 17844389111     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940490518865     Document Type: Article

References (24)

1. Giovanni A, Mariotti C, Ripa E, Scassellati-Sforzolini B. Indocyanine green angiographic findings in serpiginous choroidopathy. Br J Ophthalmol. 1996;80:536-540.
2. Hamilton AM, Bird AC. Geographic choroidopathy. Br J Ophthalmol. 1974;58:784-788.
3. King DG, Grizzard WS, Sever RJ, Espinoza L. Serpiginous choroidopathy associated with elevated factor VIII-Von Willebrand factor antigen. Retina. 1990;10:97-101.
4. Jampol LM, Orth D, Daily MJ, Rabb MF. Subretinal neovascularisation with geographic (serpiginous) choroiditis. Am J Ophthalmol. 1979;88:683-689.
5. Wojno T, Meredith TA. Unusual findings in serpiginous choroiditis. Am J Ophthalmol. 1982;94:650-655.
6. Hooper PL, Kaplan HJ. Triple agent immunosuppression in serpiginous choroiditis. Ophthalmology. 1991;98:944-951.
7. Federman JL, Gouras P, Schubert H, et al. Inflammations of the retina. In: Podos SM, Yanoff M, editors. Textbook of ophthalmology, 1st ed. Barcelona: Mosby, 1994;10,21-10,22.
8. Akpek EK, Jabs DA, Tessler HH, et al. Successful treatment of serpiginous choroiditis with alkylating agents. Ophthalmology. 2002;109(8):1506-1513.
9. Laatikainen L, Erkkila H. Serpiginous choroiditis. Br J Ophthalmol. 1974;58:777-783.
10. Becquet F, Cohen SY, Coscas G. Choroidit serpigeneuse. J F Ophtalmol. 1992;4:288-298.
11. Friberg TR. Serpiginous choroiditis with branch vein occlusion and bilateral periphlebitis. Arch Ophthalmol. 1988;106:585-586.
12. Tigh H. New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine. Gastroenterology. 1997;112(3):1017-1021.
13. Gresser I. Biologic effects of interferons. J Invest Dermatol. 1990;95:66-71.
14. Tilg H, Kaser A. Interferons and their role in inflammation. Curr Pharm Des. 1999;5:771-785.
15. Kötter I, Eckstein AK, Stubiger N, et al. Treatment of ocular symptoms of Behcet's disease with interferon alpha-2a: a pilot study. Br J Ophthalmol. 1998;82:488-494.
16. Kötter I, Zierhut M, Eckstein AK, et al. Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis. Br J Ophthalmol. 2003;87:423-431.
17. Azizlerli G, Sarica R, Kose A, et al. Interferon alfa-2a in the treatment of Behcet's disease. Dermatology. 1996;192:239-241.
18. Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987;103:234-235.
19. Anonymous. Argon laser photocoagulation for idiopathic neovascularization. Results of a randomized clinical trial. Arch Ophthalmol. 1983;101(9):1358-1361.
20. Jampol LM, Orth D, Daily MJ, Rabb MF. Subretinal neovascularization with geographic (serpiginous) choroiditis. Am J Ophthalmol. 1979;88:683-689.
21. Martidis A, Miller DG, Ciulla TA, et al. Corticosteroids as an antiangiogenic agent for histoplasmosis-related subfoveal choroidal neovascularization. J Ocul Pharmacol Ther. 1999;15:425-428.
22. Sanislo SR, Lowder CY, Kauiser PK, et al. Corticosteroid therapy for optic disc neovascularization secondary to chronic uveitis. Am J Ophthalmol. 2000;130(6):724-731.
23. Priya K, Hadhavan HN, Reiser BJ, et al. Association of herpesviruses in the aqueous humor of patients with serpiginous choroiditis: apolymerase chain reaction-based study. Ocul lmmunol lnflamm. 2002;10(4):235-238.
24. Ciardella AP, Donsoff IM, Guyer DR, et al. Antiangiogenesis agents. Ophthalmol Clin North Am. 2002;15(4):453-458.